0001437749-14-001684.txt : 20140207 0001437749-14-001684.hdr.sgml : 20140207 20140207083155 ACCESSION NUMBER: 0001437749-14-001684 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140207 DATE AS OF CHANGE: 20140207 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MDC HOLDINGS INC CENTRAL INDEX KEY: 0000773141 STANDARD INDUSTRIAL CLASSIFICATION: OPERATIVE BUILDERS [1531] IRS NUMBER: 840622967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-36619 FILM NUMBER: 14581934 BUSINESS ADDRESS: STREET 1: 4350 S MONACO STREET STREET 2: SUITE 500 CITY: DENVER STATE: CO ZIP: 80237 BUSINESS PHONE: 3037731100 MAIL ADDRESS: STREET 1: 4350 S MONACO STREET STREET 2: SUITE 500 CITY: DENVER STATE: CO ZIP: 80237 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MANDARICH DAVID D CENTRAL INDEX KEY: 0001009874 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 4350 S. MONACO STREET, SUITE 500 CITY: DENVER STATE: CO ZIP: 80237 SC 13D/A 1 mand20140206_sc13da.htm SCHEDULE 13D/A mand20140206_sc13da.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

(Amendment No. 19)

 

M.D.C. HOLDINGS, INC.

(Name of Issuer)

 

Common Stock, $0.01 Per Share

(Title of Class of Securities)

 

552676108

(CUSIP Number)

 

David D. Mandarich, 4350 S. Monaco St., Suite 500, Denver, CO 80237

(303) 773-1100

(Name, Address and Telephone Number of Person Authorized

to Receive Notices and Communications)

 

February 7, 2014

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1 (e), 13d-1(f) or 13d-1(g), check the following box [ ].

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

  

 
Page 1 of 4
 

 

CUSIP NO. 552676108

SCHEDULE 13D

Page 2 of 4 Pages

 

 

1

NAME OF REPORTING PERSON  

 

 

David D. Mandarich  

 

     
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
  Not Applicable (b) [ ]
     
3 SEC USE ONLY  
     
4 SOURCE OF FUNDS  

 

OO  

 

     

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2 (e)  

[ ]

 

Not Applicable  

 

     
6 CITIZENSHIP OR PLACE OF ORGANIZATION  
 

United States of America

  
     

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person with  

7

SOLE VOTING POWER

 

4,660,884

   

8

SHARED VOTING POWER

 

0

   

9

SOLE DISPOSITIVE POWER

 

4,660,884

   

10

SHARED DISPOSITIVE POWER

 

0

 

 

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
  4,660,884  
     
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 

[ ]

  Not Applicable  
     
13

PERCENT OF CLASS REPRESENTED BY THE AMOUNT IN ROW (11)

  
  9.2%  
     
14

TYPE OF REPORTING PERSON

  
  IN  
     

 

 
 
 

  

CUSIP NO. 552676108

SCHEDULE 13D

Page 3 of 4 Pages

 

  

Explanatory Note. This is a voluntary filing to reflect changes in Reporting Person’s holdings over the prior year.

 

The Reporting Person, David D. Mandarich, hereby amends his Schedule 13D relating to Common Stock, par value $0.01, of M.D.C. Holdings, Inc.

  

Item 5.   Interest in Securities of the Issuer
     
   

According to the Form 10-K of the Issuer dated December 31, 2013, there were 48,788,887 shares of the Issuer's Common Stock outstanding as of December 31, 2013.

     
 

(a)

Amount beneficially owned as of the close of business on February 7, 2014: 4,660,884 shares of Common Stock

     
   

Percent of class: 9.2%

 

 

(b)

The number of shares as of the close of business on February 7, 2014 as to which Reporting Person has:

     
   

(i) Sole power to vote or direct the vote: 4,660,884 shares;

     
   

(ii) Shared power to vote or direct the vote: 0 shares;

     
   

(iii) Sole power to dispose or direct the disposition of: 4,660,884 shares

     
   

(iv) Shared power to dispose or direct the disposition of: 0 shares.

     
   

The number of shares set forth in Item 5(a) includes 3,624 unitized shares held in a stock fund in the Company’s 401(k) Savings Plan which changes on a daily basis and 1,634,000 shares of Common Stock that the Reporting Person has the right to acquire within 60 days of February 7, 2014 by the exercise of options.

 

 

(c)

The following table sets forth the transactions by the Reporting Person named in response to Item 5(a) during the past sixty days.

 

 

 

Trade Date

Price per Share ($)

David D. Mandarich

                               

None.

 

 
 
 

 

CUSIP NO. 552676108

SCHEDULE 13D

Page 4 of 4 Pages

 

  

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 7, 2014.

 

 

By: /s/ David D. Mandarich

      David D. Mandarich